Editas Medicine
EDIT
$5.38
Share price
3.26%
Change (1 day)
-35.18%
Change (1 year)
Editas Medicine (EDIT) Fails to deliver data
Key failure to deliver metrics for Editas Medicine :
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: $0.08 M
- Last year FTD volume: $6.69 M
Failures to deliver for Editas Medicine (EDIT) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Editas Medicine (EDIT) - since 2016
Volume in USD (price x number of shares), data since 2016Editas Medicine (EDIT) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.09 M | -98.8% |
| 2023 | $8.24 M | -59.76% |
| 2022 | $20.49 M | -76.44% |
| 2021 | $86.97 M | 59.13% |
| 2020 | $54.65 M | 44.99% |
| 2019 | $37.69 M | -8.61% |
| 2018 | $41.24 M | 37.2% |
| 2017 | $30.06 M | -54.02% |
| 2016 | $65.38 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Organovo ONVO | $0.12 M | $0.76 M | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.21 M | $0.27 B | 🇬🇧 UK |
 Novavax NVAX | $37.88 M | $0.32 B | 🇺🇸 USA |
 Novocure
NVCR | $0.85 M | $7.42 M | Jersey |